Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA
2024-11-22 19:34
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer
2024-11-22 16:00
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
2024-11-22 12:14
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
2024-11-22 10:27
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
2024-11-22 10:15
United Imaging Announces the First of Several New U.S. Product Launches For RSNA
2024-11-22 03:00
TELUS Mental Health Index: Mental health of workers in Australia hits four-year low, costing businesses up to 69 workdays of productivity annually per employee
2024-11-22 02:00
poLight ASA receives purchase order for TWedge® wobulator technical samples from a top tier consumer OEM customer
2024-11-22 00:44
TELUS Mental Health Index: Singapore's workforce faces growing mental health crisis, threatening productivity and physical health
2024-11-22 00:01
TELUS Mental Health Index: 40 per cent of workers in New Zealand have high mental health risk as productivity losses mount
2024-11-22 00:00
The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development
2024-11-21 23:46
I-Mab to Participate at the Piper Sandler Healthcare Conference
2024-11-21 20:00
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
2024-11-21 18:30
3Shape A/S and Medit Corp. Reach Settlement in Patent Infringement Lawsuit
2024-11-21 18:18
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
2024-11-21 18:00
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
2024-11-21 16:00
InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
2024-11-21 15:09
APRIL Group Supports National Health Development in Riau Province, Indonesia
2024-11-21 13:36
DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation
2024-11-21 13:01
United Imaging Installs Another Flagship uMR OMEGA®, in New Mexico
2024-11-21 09:09
1
14
15
16
17
18
977